Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Maturitas ; 42(4): 295-300, 2002 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-12191852

RESUMO

OBJECTIVES: To compare the effect of a soy rich diet and hormone replacement therapy (HRT) on the main biomarkers of bone turnover and bone mineral density (BMD) at postmenopausal age. METHODS: 187 healthy asymptomatic postmenopausal women, aged 39-60, were recruited and randomized into a soy rich diet group, a HRT group, and a control group. Bone biomarkers and BMD were evaluated at baseline and after 6 months at the end of the study. RESULTS: Diet is not as effective as HRT in reducing the postmenopausal turnover; however diet stimulates bone osteoblastic activity, as evidenced by significant increase in osteocalcin concentrations. BMD decreases significantly only in the control group, but not in the intervention groups. CONCLUSIONS: Our data suggest that soy products could be effective in reducing the risk of osteoporosis in asymptomatic postmenopausal women, but our findings should be confirmed before recommending the diet as a valid alternative to HRT.


Assuntos
Estrogênios não Esteroides/uso terapêutico , Glycine max , Osteoporose Pós-Menopausa/prevenção & controle , Fitoterapia , Adulto , Biomarcadores/análise , Densidade Óssea/efeitos dos fármacos , Remodelação Óssea/efeitos dos fármacos , Colágeno/análise , Colágeno Tipo I , Terapia de Reposição de Estrogênios , Feminino , Humanos , Hidroxiprolina/análise , Isoflavonas/uso terapêutico , Pessoa de Meia-Idade , Osteocalcina/análise , Osteoporose Pós-Menopausa/diagnóstico , Osteoporose Pós-Menopausa/dietoterapia , Peptídeos/análise , Fitoestrógenos , Preparações de Plantas
2.
Minerva Med ; 92(5): 293-9, 2001 Oct.
Artigo em Italiano | MEDLINE | ID: mdl-11675572

RESUMO

BACKGROUND: Since tumor markers can be high in the course of many inflammatory diseases, the aim of this study is to verify if it also occurs in the course of rheumathologic chronic inflammatory diseases, and if there is any statistical correlation between tumor markers and inflammatory indices. METHODS: Seventy-nine patients (51 females and 28 males) with rheumatologic chronic inflammatory diseases, aged 17-92 years, were studied, all of them took 4 mg of prednisone. alphaFP, CEA, TPA, CA19.9, CA15.3, CA72.4, CA125, ferritina, beta2 microglobuling, betaHCG, and free and total PSA in males, were evaluated as tumor markers; and VES, PCR and Fibrinogen, as inflammatory indices. RESULTS: The results obtained showed that there is a significative correlation between ferritin, beta2 microglobulin, TPA and PCR, and between free and total PSA and Fibrinogen. CONCLUSIONS: PCR is a very good index of an active disease and it can be helpful, along with tumor markers, in the monitoring of chronic inflammatory diseases.


Assuntos
Biomarcadores Tumorais , Doenças Reumáticas , Proteínas de Fase Aguda/análise , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/análise , Biomarcadores Tumorais/sangue , Proteína C-Reativa/análise , Doença Crônica , Feminino , Marcadores Genéticos , Humanos , Masculino , Pessoa de Meia-Idade , Análise de Regressão , Doenças Reumáticas/sangue , Doenças Reumáticas/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA